The Drug Regulatory Authority of Pakistan (DRAP) is planning to conduct a series of training sessions next month to help tackle its concerns over poor compliance with pharmacovigilance requirements by most drug companies.
The training sessions will be held virtually and are aimed at registration holders (ie, manufacturers or importers of therapeutic goods),...




